Gene Therapy Recovers LCA Patient Vision – MD Magazine
MD Magazine |
Gene Therapy Recovers LCA Patient Vision
MD Magazine The tested gene therapy, voretigene neparvovec (Luxturna) from Spark Therapeutics, is currently under FDA review for potential approval by January 2018. An injection therapy, it uses a genetically-modified version of a harmless virus that's been … |
